Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
GLOBALFOUNDRIES reported Q1 2026 financial results showing revenue of $1.634 billion with solid profitability metrics exceeding guidance. The company launched its SCALE optical module for co-packaged optics and expanded a strategic partnership with Renesas Electronics, enhancing its presence in automotive and data center markets. GF also announced …
Editas Medicine announced positive first quarter 2026 results including significant advancements in its lead gene editing therapy candidate EDIT-401, which demonstrated over 90% LDL cholesterol reduction in preclinical studies. The company plans to initiate a first-in-human clinical trial by the end of 2026, with early proof-of-concept data expecte…
Cellectar Biosciences announced an oversubscribed financing round totaling up to $140 million led by Nantahala Capital and other healthcare-focused investors. The funds will support the confirmatory study and NDA filing for accelerated approval of iopofosine I 131 in WaldenstrF6m macroglobulinemia with the FDA and advance their PDC delivery platfor…
Atea Pharmaceuticals, a clinical-stage biopharmaceutical company developing oral antiviral therapies, announced it will hold a conference call and webcast on May 12, 2026, to discuss its financial results for the first quarter ended March 31, 2026, and to provide a business update. The company is advancing its pipeline with antiviral drugs targetin…
Shoals Technologies Group, a leading electrical infrastructure solutions provider for the energy transition market, reported Q1 2026 revenue of $140.6 million, a 74.9% increase year-over-year, driven by strong demand and market share gains. Despite a slight net loss of $0.3 million attributable to litigation settlement expenses, the company achieve…
First Watch Restaurant Group, Inc. announced Q1 2026 financial results showing a 17.3% increase in total revenues to $331.0 million and 2.8% same-restaurant sales growth. Despite a net loss of $2.7 million, adjusted EBITDA rose to $27.8 million. The company opened 16 new restaurants and reaffirmed its full-year growth outlook while raising the low …
Sotera Health Company announced that Alton Shader, current CEO of Viant Medical, will become CEO and join the Board of Directors on May 26, 2026, succeeding Michael B. Petras, Jr. Petras will transition to Executive Chairman to support a smooth leadership change. Shader brings over 20 years of medical industry experience with a focus on growth and …
Seres Therapeutics announced first quarter 2026 financial results showing a net loss of $19.9 million compared to net income in the prior year period, impacted by absence of payments from the 2024 VOWST sale. The company is nearing clinical data readout from an investigator-sponsored study of SER-155 for immune checkpoint inhibitor-related enteroco…
Climb Bio announces significant progress in the development of budoprutug, an anti-CD19 monoclonal antibody targeting B-cell mediated immune diseases. Positive topline Phase 1 data shows robust B-cell depletion via a subcutaneous formulation, supporting advancement to patient trials. Clinical trials for primary membranous nephropathy, immune thromb…
Fractyl Health, a clinical stage metabolic therapeutics company focused on innovative treatments for obesity and type 2 diabetes, will announce its Q1 2026 financial results and provide business updates on May 12, 2026. Additionally, CEO Dr. Harith Rajagopalan will present at the BofA Securities 2026 Health Care Conference on May 14, 2026.
Rhythm Pharmaceuticals announced first quarter 2026 financial results featuring $60.1 million in global net product revenue for IMCIVREE, a treatment for acquired hypothalamic obesity (HO) and rare genetic obesity disorders. The company reported a successful U.S. launch post FDA approval, received European Commission authorization expanding indicat…
NRx Pharmaceuticals initiated commercial manufacturing of its preservative-free ketamine product utilizing an innovative blow-fill-seal process at a US-based facility. The product aims to address ongoing supply shortages in sterile intravenous ketamine, with production capacity supporting significant sales and scalability. This new formulation excl…
Eupraxia Pharmaceuticals reported encouraging EREFS (Endoscopic Reference Score) data from the ongoing Phase 1b/2a RESOLVE trial evaluating EP-104GI for eosinophilic esophagitis (EoE). The data show that a higher number of esophageal wall injections (20 injections) resulted in significant improvement in inflammation and fibrosis scores, supporting …
Ocular Therapeutix announced its first quarter 2026 financial results along with significant clinical progress in its AXPAXLI program for wet age-related macular degeneration (wet AMD) and diabetic retinopathy. Key highlights include positive Phase 3 SOL-1 trial results demonstrating superiority over existing anti-VEGF treatment, initiation of the …
EVgo Inc. announced strong first quarter 2026 financial results, achieving record revenues of $110 million, a 45% increase year-over-year. The company expanded its public fast charging stalls by 25% to 5,280 and grew network throughput by 10%, reinforcing its leadership in the U.S. EV charging market. Key strategic initiatives include scaling the n…
Ryan Cohen's unsolicited $56 billion proposal for eBay strains GameStop's balance sheet logic and investor patience. With the stock under pressure, deteriorating technicals and heavy short interest, there's a high-probability trade setup to the downside over the next 45 trading days. Entry, stop and target given with clear risk framing.
Brazil's finance minister Dario Durigan said the government's relaunched consumer debt relief program is unlikely to derail the country's nascent cycle of monetary easing, describing the fiscal effect as 'quite contained.' Durigan tied current monetary pressures to geopolitical events that have pushed oil prices higher and reiterated opposition to …
KKR reported stronger fee income and a boost in dealmaking in the first quarter, as the firm raised $28 billion of new capital with flows concentrated in its credit franchise. Adjusted net income rose to $1.2 billion, while some private equity and credit fund returns softened compared with the previous twelve months.
Leidos Holdings raised its 2026 profit and revenue guidance on May 5, citing stronger-than-expected demand for its IT and military intelligence offerings. Growth in its intelligence and digital business, a recent $869 million Army contract for AI-enabled decision systems, and broader Pentagon efforts to replenish weapons stockpiles contributed to t…
EnerSys sits at the intersection of industrial motive power (forklifts), telecom/data-center backup power, and specialty defense applications. With a market cap near $7.8B, improving margins, healthy cashflow, and exposure to a forklift battery market projected to grow to $38.5B by 2030, EnerSys offers a risk-adjusted long idea. Entry, stop and tar…
Harley-Davidson unveiled a strategic reset that prioritizes more affordable motorcycles, a strengthened dealer network and higher-margin parts and accessories to restore volumes and profitability. The plan, announced under CEO Artie Starrs, targets more than $350 million in motorcycle core profit by 2027 and over $150 million in cost reductions whi…
Ferrari announced its preliminary Q1 2026 financial results showing a 3% increase in net revenues to €1,848 million and a slight rise in net profit to €413 million, supported by enriched product mix, personalized sports cars, and strong performance across sports cars, racing, and lifestyle segments. Despite geopolitical tensions, Ferrari maintained…
Micron (MU) has ripped higher into AI-driven memory demand and supply constraints. Fundamentals - strong free cash flow, low leverage, and diversified manufacturing - support further upside as an industry-wide helium and capacity squeeze deepens. This trade idea lays out an actionable long with entry, stop, and target, plus catalysts and explicit r…
Morgan Stanley's consumer coverage outperformed the Sensex on average in April, with roughly 90% of the stocks it covers beating the index versus about 60% in March. Food and beverage companies led the monthly advance, while longer-term returns and valuation metrics show a more mixed picture, including pronounced declines for several paint and indu…
SentinelOne reported growth but a soft fourth quarter and deteriorating profit metrics leave the stock vulnerable. At roughly $15.70 and a ~5x price-to-sales multiple, the company’s positives (AI-native platform, $1B revenue in 2025) are priced in. This trade idea outlines a mid-term short (45 trading days) with clear entry, stop and target, risk f…
